Zacks Investment Management Amneal Pharmaceuticals, Inc. Transaction History
Zacks Investment Management
- $11.4 Billion
- Q2 2025
A detailed history of Zacks Investment Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 45,963 shares of AMRX stock, worth $459,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,963
Previous 48,334
4.91%
Holding current value
$459,630
Previous $405,000
8.4%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMRX
# of Institutions
252Shares Held
146MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$176 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$123 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$117 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$113 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$56.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.51B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...